Concepedia

Hirak Der‐Torossian

HD

22

Publications

2.4K

Citations

18

H-Index

2012

Active since

Affiliations

Mirati Therapeutics (United States)(Current)

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Virginia Cancer Specialists

Sarah Cannon

Hirak Der‐Torossian is an author at Mirati Therapeutics (United States) specializing in medicine, cancer therapeutics, and molecular oncology.

ORCID

Top concepts

Publications per year

2012–2024

22

Publications

22

Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation

Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2022 · 886 citations · Full text

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated <i>KRAS</i> G12C

Rona Yaeger, Jared Weiss, Meredith Pelster et al. · New England Journal of Medicine · 2022 · 440 citations · Full text

Adagrasib in Advanced Solid Tumors Harboring a<i>KRAS</i><sup><i>G12C</i></sup>Mutation

Tanios Bekaii‐Saab, Rona Yaeger, Alexander I. Spira et al. · Journal of Clinical Oncology · 2023 · 244 citations · Full text

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli et al. · Cancer Discovery · 2022 · 122 citations · Full text

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with <i>KRAS</i> G12C-Mutated Metastatic Colorectal Cancer

Rona Yaeger, Nataliya V. Uboha, Meredith S. Pelster et al. · Cancer Discovery · 2024 · 88 citations · Full text

Rows per page

1–5 of 22